Definitive Contract HHSN272201700059C
Award Date
7/27/17
Potential Completion Date
8/31/22
Potential Value
$25M
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Seattle Children's Hospital
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $32,903,521.00 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Seattle Children's Hospital for scientific support to the Centers for Research on Structural Biology of Infectious Diseases. The contract has no set-aside designation. As the prime contractor, Seattle Children's Hospital is collaborating with several major subcontractors, including the University of...
The National Institute of Allergy and Infectious Diseases awarded a $87,790,431 definitive contract to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, to support the Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB) program. This contract has no set-aside designation. Under the contract, Seattle Children's Hospital will coordinate various research activities across multiple subcontractors, including the University of...
This is a federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Washington (UW). The contract, valued at $7,822,728.37, is for biomedical research services under the Population Genetics Analysis Program. The contract is a definitive, cost-no-fee type and does not have a set-aside designation.
UW is a leading public research university that has extensive experience in supporting federal agencies through prime contract and grant...
This $5,635,564.60 cost-reimbursable definitive contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Fred Hutchinson Cancer Center (doing business as Seattle Cancer Care Alliance), a non-profit medical research organization. The contract supports targeted clinical research to address select viral infections. There was no set-aside designation.
Under the contract, Fred Hutchinson Cancer Center is...
This is a federal contract award from the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Northwestern University. The award is a 5-year definitive contract with a potential value of $25,631,560.21 to support the "Structural Genomics Centers for Infectious Diseases" program. This contract does not have a set-aside designation.
As the prime contractor, Northwestern University will provide research,...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the University of Washington School of Medicine. The $23,012,457.00 firm-fixed-price contract is for specialized biomedical services and laboratory testing to support federal healthcare and research initiatives. The School of Medicine, which is a part of the University of Washington, has extensive expertise in clinical pathology,...
This is a federal contract award to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, a leading pediatric healthcare and research institution in Seattle, Washington. The contract, with a ceiling value of $84,691.29, was awarded by the U.S. Department of Health and Human Services (HHS) on September 18, 2015, and has an ultimate completion date of February 1, 2018. The contract is a definitive contract with a firm fixed price pricing type. No set-aside was...
This is a $5,491,304.00 cost-reimbursement contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the University of Washington (UW) to conduct large-scale T-cell epitope discovery research. The contract has a completion date of September 29, 2025 and is not a set-aside award.
As the prime contractor, UW will perform the research work. UW has a subcontract with Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), a foreign government hospital, to...
This is a $18,576,013.05 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Access To Advanced Health Institute (AAHI), a non-profit biotech research institute located in Seattle, Washington. The contract is for the development of vaccine candidates to address biodefense, antimicrobial resistant infections, and emerging infectious diseases. AAHI, which does...
This is a $37,252,988 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, for the "IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)" project. The contract has a period of performance through July 31, 2028 and does not utilize any set-aside designations.
The contract supports research to examine innate and adaptive...